Autor(es): Haug B. A.; Dressler D.; Prange H. W.

Resumo: The development of Guillain-Barré syndrome is reported in a patient, who had previously received botulinum toxin type A injections into both orbicularis oculi muscles to treat idiopathic blepharospasm. The possibility of a causal relationship is discussed with consideration of the literature on adverse effects of vaccinations and of Clostridium botulinum and its toxin.

Imprenta: Journal of Neurology, v. 237, n. 1, p. 62-63, 1990

Identificador do objeto digital: 10.1007/BF00319673

Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins

Data de publicação: 1990

INDICADORES

ACESSO